2 min read

UBC Cited in Publication for Smallpox Vaccine Safety Surveillance Study

The prospective study included the enrollment 20,136 active-duty military subjects.
"Learn more about this prospective study including the enrollment of 20,136 subjects who were active-duty military personnel.

UBC is pleased to be cited in a recent publication of a smallpox vaccine study in the journal entitled, Vaccine

UBC recently participated in a smallpox safety surveillance study. This prospective study included the enrollment of 20,136 subjects who were active-duty military personnel undergoing pre-deployment medical readiness. The trial was initiated to address safety concerns relating to myopericarditis.

Vaccine is the official journal of The Edward Jenner Society and The Japanese Society for Vaccinology. The literature article was published here on September 13, 2020, with contributions from the Naval Health Research Center, Sanofi Pasteur Inc, Emergent BioSolutions, the Department of Health Policy, Vanderbilt University School of Medicine, and UBC.

From conducting clinical trials to meeting post-approval regulatory requirements, we can help guide your infectious disease product or vaccine on its critical path to rapid approval and beyond. UBC’s leadership team have authored and supported countless submissions to regulatory authorities and remain current on the latest global regulatory trends and changes. To learn more about our experience and to discuss how we can support your clinical development, head here.

D. J. Faix, D. M. Gordon, L. N. Perry et al., Prospective safety surveillance study of ACAM2000 smallpox vaccine in deploying military personnel, Vaccine, https://doi.org/10.1016/j.vaccine.2020.09.037

Other Recent Posts

1 min read

UBC Listed as a Citeline Awards Finalist for Excellence in RWE

UBC is once again a finalist for the Citeline Awards, with our 2024 nomination coming in the Excellence in RWE category.
5 min read

UBC Successfully Implemented REMS Administration Software During HL7® FHIR® Connectathon

UBC demonstrated our commitment to optimizing safe medication use and health outcomes by participating in the HL7® FHIR® Connectathon.
5 min read

UBC Selects Oracle Cloud Safety Technology for its Safety Programs

UBC selected Oracle Life Sciences' safety case management solution.

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.